美国FDA药品数据库（U.S. FDA Drugs Database）
符合检索条件的记录共 12 条
共 1 页，当前第 1 页
| 商品名 |
申请号 |
产品号 |
申请类型 |
活性成分 |
剂型/给药途径 |
规格/剂量 |
RLD |
RS |
申请号原始批准/暂定批准日期 |
产品号批准日期 |
申请人 |
市场状态 |
| TALZENNA |
211651 |
001 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 0.25MG BASE |
Yes
|
No
|
2018/10/16
|
2018/10/16
|
PFIZER |
Prescription |
| TALZENNA |
211651 |
002 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 1MG BASE |
Yes
|
Yes
|
2018/10/16
|
2018/10/16
|
PFIZER |
Prescription |
| TALZENNA |
211651 |
003 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 0.5MG BASE |
Yes
|
No
|
2018/10/16
|
2021/09/20
|
PFIZER |
Prescription |
| TALZENNA |
211651 |
004 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 0.75MG BASE |
Yes
|
No
|
2018/10/16
|
2021/09/20
|
PFIZER |
Prescription |
| TALZENNA |
211651 |
005 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 0.1MG BASE |
Yes
|
No
|
2018/10/16
|
2023/06/20
|
PFIZER |
Prescription |
| TALZENNA |
211651 |
006 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 0.35MG BASE |
Yes
|
No
|
2018/10/16
|
2023/06/20
|
PFIZER |
Prescription |
| TALZENNA |
217439 |
001 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 0.1MG BASE |
Yes
|
No
|
2024/03/07
|
2024/03/07
|
PFIZER |
Prescription |
| TALZENNA |
217439 |
002 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 0.25MG BASE |
Yes
|
No
|
2024/03/07
|
2024/03/07
|
PFIZER |
Prescription |
| TALZENNA |
217439 |
003 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 0.35MG BASE |
Yes
|
No
|
2024/03/07
|
2024/03/07
|
PFIZER |
Prescription |
| TALZENNA |
217439 |
004 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 0.5MG BASE |
Yes
|
No
|
2024/03/07
|
2024/03/07
|
PFIZER |
Prescription |
| TALZENNA |
217439 |
005 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 0.75MG BASE |
Yes
|
No
|
2024/03/07
|
2024/03/07
|
PFIZER |
Prescription |
| TALZENNA |
217439 |
006 |
NDA |
TALAZOPARIB TOSYLATE |
CAPSULE;ORAL |
EQ 1MG BASE |
Yes
|
Yes
|
2024/03/07
|
2024/03/07
|
PFIZER |
Prescription |